Marie Kosco-Vilbois, PhD

Chief Scientific Officer at NovImmune SA

Speaker

CSO of Novimmune SA, responsible for overseeing the discovery and development of antibody-based drugs for the targeted treatment of inflammatory and rare diseases, immune-related disorders and cancer. Prior industry experience includes GlaxoWellcome, Serono and Roche, the latter as a scientific member of the Basel Institute for Immunology. Holds a doctorate in Immunology and Human Anatomy from the Medical College of Virginia, USA, author of numerous peer-reviewed publications in the fields of immunology and biopharmaceutical research, especially as related to antibody generation and antibodies as therapeutics.